Citigroup’s Alexza Pharmaceuticals Inc ALXA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q2 | – | Sell |
-602
| Closed | – | – | 7787 |
|
|
2016
Q1 | $0 | Sell |
602
-8
| -1% | -$4 | ﹤0.01% | 8074 |
|
|
2015
Q4 | $0 | Buy |
+610
| New | +$629 | ﹤0.01% | 8153 |
|
|
2015
Q3 | – | Sell |
-5,412
| Closed | -$6K | – | 8110 |
|
|
2015
Q2 | $6K | Buy |
+5,412
| New | +$8.12K | ﹤0.01% | 6711 |
|
|
2015
Q1 | – | Sell |
-957
| Closed | -$1K | – | 7648 |
|
|
2014
Q4 | $1K | Buy |
957
+757
| +379% | +$1.35K | ﹤0.01% | 7047 |
|
|
2014
Q3 | $0 | Hold |
200
| – | – | ﹤0.01% | 7492 |
|
|
2014
Q2 | $1K | Sell |
200
-1,620
| -89% | -$7K | ﹤0.01% | 7043 |
|
|
2014
Q1 | $8K | Buy |
1,820
+1,620
| +810% | +$8.31K | ﹤0.01% | 6457 |
|
|
2013
Q4 | $1K | Hold |
200
| – | – | ﹤0.01% | 6921 |
|
|
2013
Q3 | $1K | Sell |
200
-1,000
| -83% | -$4.71K | ﹤0.01% | 6737 |
|
|
2013
Q2 | $5K | Buy |
+1,200
| New | +$5.44K | ﹤0.01% | 6346 |
|
Citigroup's ALXA Position: Q2 2016 in Review
Citigroup sold out of Alexza Pharmaceuticals Inc (ALXA) in Q2 2016, closing a stake of 602 shares.
Citigroup first reported a position in ALXA in Q2 2013 and held it in 10 quarters. The position peaked at $8K in Q1 2014. 0 funds tracked by Wall St. Rank hold ALXA as of Q2 2016.
- Citigroup reported no remaining Alexza Pharmaceuticals Inc position as of Q2 2016 after selling out during the quarter.
- Citigroup sold 602 Alexza Pharmaceuticals Inc shares in Q2 2016.
- Citigroup first reported a position in Alexza Pharmaceuticals Inc in Q2 2013 and held it in 10 quarters.
- Citigroup's Alexza Pharmaceuticals Inc position peaked at $8K in Q1 2014.
- 0 funds tracked by Wall St. Rank held Alexza Pharmaceuticals Inc as of Q2 2016.
Based on Citigroup's 13F filing for Q2 2016, filed 12 Aug 2016.